Aehr (AEHR) Q3 2024: WaferPak Share Hits 63% as Segment Diversification Offsets Silicon Carbide Softness
Wafer-level test and burn-in leader Aehr saw a sharp revenue reset amid silicon carbide order delays, but the company’s pivot to recurring WaferPak revenues and new segment traction in gallium nitride, photonics, and memory signal a more diversified growth path. Management’s tone shifted to cautious realism on near-term EV market demand, yet emphasized a robust pipeline of global engagements and a rising mix of high-margin consumables. Investors should track the pace of new customer conversions and the timing of delayed system ramps as Aehr seeks to stabilize through industry cycles.
Summary
- Recurring Revenue Surge: WaferPak consumables now anchor over half of sales, buffering hardware volatility.
- EV and Asia Pivot: Near-term order softness in U.S. EVs is offset by strengthening demand and direct engagement in Asia.
- Segment Expansion: Gallium nitride, photonics, and memory initiatives position Aehr for broader secular growth beyond silicon carbide.
Business Overview
Aehr Test Systems provides semiconductor wafer-level test and burn-in equipment, enabling manufacturers to screen out defective chips before assembly. The business model combines capital equipment sales (FOX systems) with recurring proprietary consumables (WaferPak contactors), supporting mission-critical applications in automotive, data center, photonics, and memory. Key segments include silicon carbide (power devices for EVs), gallium nitride, silicon photonics, and memory semiconductors.
Performance Analysis
Aehr’s third quarter reflected a pronounced revenue drop as major silicon carbide customers delayed system orders and shipment timing, particularly in the EV supply chain. Management cited industry-wide softness in semiconductor capital spending and inventory-driven order pushouts, with the impact most acute in automotive-related demand. Despite this, recurring WaferPak revenues surged to 63% of total sales, underscoring the growing importance of consumables as a stabilizing force. The WaferPak business, proprietary contactors required for each new chip design, now represents the majority of company revenue, up from 37% a year ago.
Gross margin contraction was driven by lower system shipment volume and under-absorption of overhead, but operating expenses remained tightly managed, with R&D investment prioritized to support next-generation automation and product differentiation. Backlog stood at $20M exiting the quarter, with management confident that most will convert to revenue in Q4. The company reaffirmed its full-year guidance despite near-term volatility, emphasizing a healthy cash position and zero debt.
- WaferPak Mix Shift: Recurring consumables now drive the majority of revenue, providing a buffer against system order cyclicality.
- System Order Volatility: Delays in silicon carbide system orders, especially for EV applications, directly impacted top-line results.
- R&D Investment: Continued spend on automation and new segment capabilities positions Aehr for future customer wins.
While headline revenue contracted sharply, the underlying business model is increasingly anchored by higher-margin, repeatable WaferPak sales, and management’s focus on new verticals aims to reduce reliance on any single end market.
Executive Commentary
"We now expect [order softness] to last for another quarter or two before the orders resume based on the latest roll-up of direct forecasts from over a dozen silicon carbide companies."
Gayn Erickson, President and CEO
"WaferPak revenues were $4.8 million, and accounted for 63% of our total revenue in the third quarter, which is higher than 37% of total revenue in the prior year of Q3."
Chris Hsu, Chief Financial Officer
Strategic Positioning
1. WaferPak Recurring Revenue Model
The proprietary WaferPak contactor, required for each new chip design, is emerging as Aehr’s most resilient and scalable revenue stream. With new design volume nearly doubling year-over-year, WaferPak sales are expected to comprise over half of total revenue for the full year, supporting margin stability and a more predictable business cadence.
2. Asia Expansion and EV Market Diversification
Management is doubling down on Asia, particularly China and South Korea, where EV adoption and silicon carbide demand remain robust despite U.S. softness. Aehr is expanding its local presence, infrastructure, and support to capture share, and sees direct engagement with Asian OEMs as critical for future growth. Asia’s move toward module-based silicon carbide inverters aligns with Aehr’s wafer-level burn-in value proposition.
3. Broadening End-Market Exposure
The company is actively pursuing growth in gallium nitride (GaN), silicon photonics, and memory, each with distinct technical requirements and reliability needs that favor wafer-level test. Recent wins in GaN and photonics reflect Aehr’s platform flexibility, while ongoing memory engagements signal a path to long-term secular growth as data center and AI module complexity rises.
4. Technology and IP Defensibility
Aehr is investing in automation, system flexibility, and IP protection, particularly around its FOX platform and software stack, to maintain differentiation as it enters new markets and faces local competition in China. Management highlighted ongoing steps to secure proprietary technology and adapt to evolving local supply chain requirements.
5. Customer Conversion and Pipeline Health
Despite order delays, the customer pipeline remains active, with multiple NP (engineering) customers expected to convert to XP (production) systems over the next two years. Management noted that all NP customers plan to scale to XP, and that Aehr has yet to lose a competitive evaluation since launching its current platform.
Key Considerations
This quarter underscores both the cyclicality of capital equipment sales and the strategic value of recurring consumables, as Aehr navigates through a period of demand volatility in its largest segment.
Key Considerations:
- WaferPak Leverage: The shift to consumables-driven revenue provides margin and cash flow resilience, especially during system order lulls.
- Asia Opportunity: Direct engagement and infrastructure buildout in Asia position Aehr to capture outsized share as local EV and power device markets accelerate.
- Segment Diversification: GaN, photonics, and memory are progressing from evaluation to production, reducing single-market dependency.
- Customer Conversion Timing: The pace at which NP customers upgrade to XP production systems will be a key determinant of medium-term growth.
- R&D and IP Investment: Ongoing spend on automation and IP protection is critical for sustaining differentiation, particularly in China.
Risks
Order timing uncertainty remains elevated, especially in the silicon carbide and EV verticals, where macro and inventory dynamics can shift rapidly. Exposure to China introduces regulatory, IP, and local supply chain risks, and local subsidies may pressure margins or require system reengineering. Execution risk exists in scaling new segments (GaN, photonics, memory) from pilot to volume, and delays in customer conversions could prolong revenue lumpiness.
Forward Outlook
For Q4, Aehr guided to:
- Majority of $20M backlog recognized as revenue
- Return to profitability after Q3 loss
For full-year 2024, management reaffirmed guidance:
- Revenue above $65M
- Net income of at least $11M
Management highlighted several factors that will shape the outlook:
- Potential for resumed silicon carbide system orders after one to two quarters of softness
- Increasing engagement and likely measurable revenue in Asia, especially China, in fiscal 2025
Takeaways
Aehr is leveraging its recurring WaferPak business to weather near-term volatility, while broadening its addressable market across power, photonics, and memory segments.
- Recurring Revenue Resilience: The WaferPak mix shift provides a margin and cash flow buffer against system order cyclicality, supporting long-term model stability.
- Asia and Segment Expansion: Direct engagement in Asia, combined with traction in GaN and photonics, positions Aehr for diversified growth as silicon carbide order timing normalizes.
- Customer Conversion Watchpoint: Investors should closely monitor the timing and scale of NP-to-XP conversions, as these will drive revenue inflection as new markets mature.
Conclusion
Aehr’s Q3 marked a tactical reset, but the company’s business model evolution toward consumables and segment diversification lays the groundwork for more durable growth. Execution in Asia and new verticals will be critical to restoring momentum and delivering on the long-term secular opportunity in wafer-level test and burn-in.
Industry Read-Through
The quarter highlights a broader theme across semiconductor capital equipment: recurring consumables and installed base leverage are becoming essential for navigating industry cycles. Order pushouts in EV and silicon carbide reflect macro and inventory headwinds facing the entire auto supply chain, but robust demand in Asia and the rise of module-based architectures signal a shift in global market leadership. Segment diversification into GaN, photonics, and memory is a strategic imperative for all test and burn-in vendors as AI, data center, and automotive reliability standards increase. For peers, the ability to pivot from hardware to high-margin consumables and to localize solutions for Asia will be key competitive differentiators in the coming cycle.